NCT01444690

Dimiracetam in Painful Neuropathies Affecting AIDS Patients

Dimiracetam in Painful Neuropathies Affecting AIDS Patients. A Double-blind, Placebo-controlled, Parallel-group, Randomised, Multi-centre Study

• Status: Unknown
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 244 (estimated)
• Sponsor: Neurotune AG · Industry
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to assess the efficacy and tolerability of orally administered dimiracetam for 10 weeks to AIDS patients under treatment with antiretroviral agents presenting a disease and /or treatment related neuropathic pain.

Conditions

• Acquired Immunodeficiency Syndrome

Interventions

Type	Name	Description
DRUG	Dimiracetam	Capsules for oral administration twice daily
DRUG	Dimiracetam 25 mg	Inactive dose level in capsules administered orally twice daily

Timeline

• Start date: 2012-01-01
• Primary completion: 2013-01-01
• Completion: 2013-01-01
• First posted: 2011-10-03
• Last updated: 2011-10-03

Locations

1 site across 1 country: Switzerland